Sort by title | Sort by title | Sort by price | Sort by price
The Acetylcholine Receptor Binding Antibody (AChR) test is a blood test used to detect antibodies targeting acetylcholine receptors, crucial for muscle movement. In autoimmune disorder myasthenia gravis, the body produces antibodies that attack these receptors, causing muscle weakness and fatigue. The AChR test measures the levels of these antibodies, aiding in the diagnosis of myasthenia gravis. However, it is used in conjunction with other clinical assessments like a physical exam and other tests. Treatment may involve medications or surgery. If experiencing muscle weakness and fatigue, especially worsening with activity, consulting a healthcare provider for evaluation and potential AChR testing is crucial.
The ANA blood test, or Antinuclear Antibody test, detects antibodies that target the body's own tissues, potentially indicating autoimmune diseases like lupus or rheumatoid arthritis. While symptoms like joint pain or fatigue prompt its use, a positive result doesn't always mean disease. Further testing and consultation with healthcare providers are necessary for accurate diagnosis and treatment planning.
The Autoimmune Disorder Panel is a series of blood tests that detect antibodies associated with autoimmune disorders, where the immune system attacks healthy tissues. Tests in the panel identify specific antibodies linked to conditions like rheumatoid arthritis, lupus, and celiac disease. Results guide diagnosis, treatment decisions, and provide information on disease activity. The panel may also include tests for inflammation markers. Results, combined with medical history and other tests, are used to accurately diagnose and plan treatment. Treatment typically involves medications to suppress the abnormal immune response, manage symptoms, and reduce inflammation.
The C-Reactive Protein (CRP) test measures levels of a liver-produced protein that increases in response to inflammation. It is used to diagnose and monitor inflammatory conditions, autoimmune diseases, and assess cardiovascular disease risk. Healthcare providers order the test for symptoms of inflammation and to evaluate treatment effectiveness. Interpretation should consider other clinical factors, as elevated CRP levels can be influenced by various factors. Follow-up testing and consultation with a healthcare provider are crucial for accurate diagnosis and treatment planning based on CRP test results.
High Sensitivity C-Reactive Protein (hs-CRP) is a blood test that detects C-reactive protein levels with high sensitivity, indicating inflammation in the body. It is used to assess the risk of cardiovascular disease and monitor inflammatory conditions like autoimmune diseases. Elevated levels of hs-CRP are associated with a higher risk of heart attacks and strokes. Results are reported in milligrams per liter, with different levels indicating varying risks. The test is influenced by factors like smoking, obesity, and chronic conditions, and may require multiple tests for accuracy. While not diagnostic alone, hs-CRP is used in combination with other factors to assess cardiovascular risk and guide treatment decisions.
The ESR test measures the rate at which red blood cells settle at the bottom of a tube of blood over a specific period of time. It is a non-specific test that can indicate the presence of inflammation in the body. A higher ESR rate may be caused by conditions such as infections, autoimmune diseases, and certain types of cancer. However, it is important to note that a high ESR rate can also be caused by non-inflammatory conditions, so further testing may be needed to determine the underlying cause.
A lupus panel is a blood test used to diagnose and monitor systemic lupus erythematosus (SLE), an autoimmune disease. It includes tests for specific antibodies like ANA and anti-dsDNA, common in lupus patients. Results aid in diagnosing and tracking disease progression.
Rheumatoid arthritis (RA) is an autoimmune condition that causes joint inflammation, pain, swelling, and stiffness. The Rheumatoid Factor (RF) test is a blood test that detects antibodies in response to inflammation, often associated with RA, but can also be found in other conditions. A positive RF test doesn't always mean RA, and not all RA cases show positive results. It is one of several tests used for diagnosis, alongside anti-CCP test and imaging studies. Clinical evaluation by a healthcare provider is crucial for an accurate diagnosis. Early detection and treatment of RA help manage symptoms and improve quality of life. If you suspect RA symptoms, seek medical evaluation for appropriate management.
USLABTESTING